Symphony has reported significant product development and regulatory approval. Most notably it has received enhanced US Food & Drug Administration (FDA) and Health Canada approval for introduction of d2p anti-microbial technology for bread packaging in these markets. Our analysis shows the total market in North America for bread products is valued at c.$24bn each year. In the recent H1 statement, the Group reported revenue growth of 13% to £5.4m (at constant FX) but a loss before tax of £0.6m (i ....